76 related articles for article (PubMed ID: 7000652)
1. Pancreatic alpha and beta cell function in familial dysbetalipoproteinemia.
Tan MH; Havel RJ; Gerich JE; Soeldner JS; Kane JP
Horm Metab Res; 1980 Sep; 12(9):421-5. PubMed ID: 7000652
[TBL] [Abstract][Full Text] [Related]
2. [Endocrine pancreas function in mucoviscidosis].
Knöpfle G
Klin Padiatr; 1985; 197(1):13-20. PubMed ID: 3883047
[TBL] [Abstract][Full Text] [Related]
3. Maximal stimulation of pancreatic islet B-cells, and A-cell response to arginine, in dogs with longterm pancreatic acinar atrophy.
Meister R; Berger I; Schwille PO; Gebhardt C
Eur J Surg; 1991 May; 157(5):333-40. PubMed ID: 1678647
[TBL] [Abstract][Full Text] [Related]
4. Studies of glucose intolerance in cirrhosis of the liver.
Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
[TBL] [Abstract][Full Text] [Related]
5. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
6. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
Alvestrand A; Mujagic M; Wajngot A; Efendic S
Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
[TBL] [Abstract][Full Text] [Related]
7. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
8. Selective induction of inducible nitric oxide synthase in pancreatic islet of rat after an intravenous glucose or intralipid challenge.
Ekelund M; Qader SS; Jimenez-Feltstrom J; Salehi A
Nutrition; 2006 Jun; 22(6):652-60. PubMed ID: 16635563
[TBL] [Abstract][Full Text] [Related]
9. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
Emara MK; Saadah A; Hassan M; Moussa M; Hourani H
Diabetes Res; 1989 Apr; 10(4):175-81. PubMed ID: 2692944
[TBL] [Abstract][Full Text] [Related]
10. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
[TBL] [Abstract][Full Text] [Related]
11. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
Valverde I; Puente J; Martín-Duce A; Molina L; Lozano O; Sancho V; Malaisse WJ; Villanueva-Peñacarrillo ML
Obes Surg; 2005 Mar; 15(3):387-97. PubMed ID: 15826475
[TBL] [Abstract][Full Text] [Related]
12. The influence of plasma triglycerides on human growth hormone response to arginine and insulin: a study in hyperlipemics and normal subjects.
Muggeo M; Tiengo A; Fedele D; Crepaldi G
Horm Metab Res; 1975 Sep; 7(5):367-74. PubMed ID: 1183914
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
[TBL] [Abstract][Full Text] [Related]
14. Plasma glucagon in obesity. Response to arginine, glucose and protein administration.
Kalkhoff RK; Gossain VV; Matute ML
N Engl J Med; 1973 Aug; 289(9):465-7. PubMed ID: 4587235
[No Abstract] [Full Text] [Related]
15. Insulin and glucagon response to glucose and arginine in two patients with "autoimmune" diabetes mellitus.
Del Prete GF; Tiengo A; Bersani G; Nosadini R; Garotti C; Trisotto A
Horm Metab Res; 1976 Mar; 8(2):149-50. PubMed ID: 1261966
[No Abstract] [Full Text] [Related]
16. Hyperglucagonemia in myotonic dystrophy.
Suzuki H
J Clin Endocrinol Metab; 1981 Apr; 52(4):790-5. PubMed ID: 7009630
[TBL] [Abstract][Full Text] [Related]
17. Relationship between secretory capacity of pancreatic A cell and of B cell.
Shima K; Tanaka R; Sawazaki N; Kumahara Y
Horm Metab Res; 1979 Jul; 11(7):451-2. PubMed ID: 383596
[No Abstract] [Full Text] [Related]
18. Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients.
Roti E; Braverman LE; Robuschi G; Salvi M; Gardini E; d'Amato L; Maestri D; Montermini M; Borciani E; Pezzarossa A
Metabolism; 1986 Apr; 35(4):337-42. PubMed ID: 3515118
[TBL] [Abstract][Full Text] [Related]
19. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
[TBL] [Abstract][Full Text] [Related]
20. Endocrine pancreatic function in pheochromocytoma.
Sicolo N; Federspil G; De Palo CB; Vettor R; Martini C; Scandellari C
J Endocrinol Invest; 1991 Mar; 14(3):225-9. PubMed ID: 2071824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
